2023
Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature
WHITLEY, Adam, Petr KOCIAN, Andrej NIKOV, Denisa KREJČÍ, Lucie KŮSOVÁ et. al.Základní údaje
Originální název
Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature
Autoři
WHITLEY, Adam, Petr KOCIAN (203 Česká republika, garant), Andrej NIKOV, Denisa KREJČÍ (203 Česká republika, domácí), Lucie KŮSOVÁ (203 Česká republika, domácí), Milan BLAHA (203 Česká republika, domácí), Ladislav DUŠEK (203 Česká republika, domácí) a Robert GURLICH (203 Česká republika)
Vydání
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Hoboken, WILEY, 2023, 1868-6974
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30219 Gastroenterology and hepatology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.000 v roce 2022
Kód RIV
RIV/00216224:14110/23:00133339
Organizační jednotka
Lékařská fakulta
UT WoS
001073545100001
Klíčová slova anglicky
adult; pancreatic neoplasms; population register; survival; young adult
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 4. 2024 09:23, Mgr. Tereza Miškechová
Anotace
V originále
Background: The aim of this study was to compare trends in mortality and incidence, clinicopathological features and survival of patients diagnosed with pancreatic ductal adenocarcinoma under 50 years of age (early-onset pancreatic cancer [EOPC]) with patients diagnosed over 50 years of age (late-onset pancreatic cancer [LOPC]).Methods: The national oncological registry of the Czech Republic was reviewed to identify all patients with histologically confirmed pancreatic ductal adenocarcinoma diagnosed between the years 1985 and 2015. Incidence, mortality, clinicopathological and survival data were analyzed and compared between patients with EOPC and LOPC.Results: From a total of 18 888 patients included in the study, 1324 patients were under the age of 50 years (7.0%). The average annual percentage changes (AAPC) in incidence of all patients with EOPC was -1.0%. The APPC for male patients with EOPC was -2.0% and for female patients was +0.6%. The AAPC in incidence for LOPC was +1.3%. There were no differences in tumor stage, grade or location between EOPC and LOPC. Young patients were more frequently male (64.4% vs. 52.9%), more frequently underwent treatment and had better overall survival. The median survival interval for EOPC was 5.9 months and for LOPC was 4.5 months (p < .001).Conclusions: The clinicopathological features of pancreatic ductal adenocarcinoma were similar in patients under and over the age of 50 years. Patients with EOPC survived longer than patients with LOPC. Continued efforts should be made to diagnose early and treat young patients aggressively.